Gilead Sciences, Inc. (GILD)
146.89
-0.75
(-0.51%)
USD |
NASDAQ |
Feb 25, 15:33
Gilead Sciences Market Cap : 182.24B for Feb. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 206.83B |
| Johnson & Johnson | 590.70B |
| Eli Lilly & Co. | 974.45B |
| Regeneron Pharmaceuticals, Inc. | 83.13B |
| Moderna, Inc. | 20.41B |
Market Cap Related Metrics
| PE Ratio | 21.66 |
| PS Ratio | 6.268 |
| PEG Ratio | 0.0124 |
| Price to Book Value | 8.057 |
| Price to Free Cash Flow | 18.40 |
| Price | 146.89 |
| Earnings Yield | 4.62% |
| PEGY Ratio | 0.0124 |
| Operating PE Ratio | 15.64 |